Connect with us

Technology

Superstate Integrates Chainlink Infrastructure To Enhance the Transparency and Utility of the USTB Tokenized Fund

Published

on

The integration helps to bring NAV onchain for Superstate’s tokenized treasury fund, USTB.

SAN FRANCISCO, Aug. 12, 2024 /PRNewswire/ — Superstate, an asset management firm modernizing investing through tokenized financial products, and Chainlink, the industry-standard decentralized computing platform, announced today the integration of Chainlink Data Feeds into Superstate’s tokenized treasury fund, the Superstate Short Duration US Government Securities Fund (USTB). This integration enables Superstate to securely bring net asset value (NAV) data onchain, enhancing the composability of the fund across the onchain financial markets.

Tokenized real-world assets, like Superstate’s USTB, require high-quality offchain data for market pricing. Superstate has addressed these needs by integrating Chainlink Data Feeds for onchain NAV data, enhancing transparency and utility for USTB. Additionally, Superstate is integrating Chainlink Proof of Reserve in the coming months, to further enhance onchain verification of AUM data.

“Asset tokenization enhances efficiency, programmability, and transparency but requires reliable onchain data to unlock DeFi and automation use cases,” said Superstate CEO and Co-founder Robert Leshner. “Our integration with Chainlink ensures transparent data for our investors, allowing us to focus more on our core business.”

NAV data is essential for both traditional and tokenized funds. USTB’s NAV data is calculated offchain by NAV Fund Services and Superstate, then accurately reported and synchronized onchain in an automated and secure manner using Chainlink’s decentralized oracle infrastructure. This enables real-time transparency, democratizes access, and creates opportunities for funds to be composable and programmable in collateralized lending, asset management, and market making.

“Superstate is playing a fundamental role in advancing infrastructure and servicing essential aspects of the rapidly growing tokenized asset economy,” said Johann Eid, Chief Business Officer at Chainlink Labs. “We’re excited to see the new use cases and opportunities Superstate will unlock by integrating the Chainlink platform to bring NAV and AUM data around its tokenized treasury fund USTB onchain.”

About Superstate
Superstate is an asset management firm modernizing the infrastructure of investment funds for crypto native institutional investors. We offer investment products that benefit from the speed, programmability, and compliance advantages of blockchain tokenization. Superstate’s suite of products includes tokenized treasury fund USTB, and tokenized crypto basis fund, USCC. Learn more about our products for institutional investors at Superstate.co.

About Chainlink
Chainlink is the industry-standard decentralized computing platform powering the verifiable web. Chainlink has enabled over $12 trillion in transaction value by providing financial institutions, startups, and developers worldwide with access to real-world data, offchain computation, and secure cross-chain interoperability across any blockchain. Chainlink powers verifiable applications and high-integrity markets for banking, DeFi, global trade, gaming, and other major sectors.

Learn more about Chainlink by visiting chain.link or reading the developer documentation at docs.chain.link.

View original content to download multimedia:https://www.prnewswire.com/news-releases/superstate-integrates-chainlink-infrastructure-to-enhance-the-transparency-and-utility-of-the-ustb-tokenized-fund-302219852.html

SOURCE Chainlink and Superstate

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Sensiva Health names Ben Williamson as Chief Executive Officer

Published

on

By

Ben Williamson to lead Sensiva Health as Dr. Jim Silliman is stepping down as CEO and will transition to The Board of Directors, effective immediately.

NEW ORLEANS, Sept. 23, 2024 /PRNewswire/ — Sensiva Health today announced that Ben Williamson has been appointed Chief Executive Officer. Williamson will start in his new role immediately as Dr. Jim Silliman transitions to the Board of Directors.

Williamson previously served as Sensiva’s Chief Operating Officer for the last 5-years overseeing operations of Sensiva Health and its laboratory, manufacturing, and technology subsidiaries. During his tenure as COO, Williamson helped grow the business in the midst of a global pandemic, adding new service lines to include diagnostic manufacturing, national logistics, and infection prevention and control. His focus and commitment to the customer experience and how it correlates directly to resident / patient care have set new standards of value in the diagnostic and senior care industries.

Major advocate of the Sensiva Shield service line, Williamson went on to make it clear that his top priority as CEO will be expanding upon Sensiva’s infection prevention and control initiative.

“The early success we’ve seen in our infection prevention and control offering (SHIELD) is testament to the fact that this important service is not only desired but needed nationally. I think we’ve done a great job at creating a scalable offering for any sized organization while providing a plethora of tools and additional service lines our competition simply can’t touch. Education and commitment to resident care are what drives this program forward and I look forward to creating strong partnerships with leading organizations nationally who understand the importance of an enterprise ICP program,” said Williamson.

Silliman is stepping down from his role as CEO and will transition to the Board of Directors with immediate effect. During his tenure, he led the Sensiva Organization through unprecedented growth while building a strong team of collaborative leaders across its 5 corporate operations nationally. In the midst of a global pandemic, Jim emphasized the importance of same day turnaround time for clinical decision-makers. To achieve this, Sensiva strengthened its internal software operation while standing up a 50,000sqft manufacturing facility to control the testing kit supply chain. At a time when other labs struggled to meet 7-day turnaround times, Sensiva consistently met same-day turnaround times to provide clinical leaders with critical information when they needed it most.

Because of the modularity of the Sensiva offering, key customers included hospital systems, public health initiatives, senior living groups, urgent care organizations, and even airlines, movie sets, and the gulf coast oil providers. Jim’s credibility, vast knowledge, and experience in the medical community continue to be a pinnacle in which Sensiva operates on.

“We are thrilled to appoint Ben as Chief Executive at Sensiva Health. Ben is a passionate, customer focused leader who brings a wealth of experience from his previous direct to consumer roles and his time as Sensiva COO. We’ve been through a lot together, and his ability to navigate problems is as impressive as his ability to quarterback a successful organization. Like everyone at Sensiva, he understands that on the other end of every Sensiva product and service is a real human (It’s not a sample, it’s a person), and that carried a lot of weight in our decision-making process,” said Silliman. “Our board believes that Ben will be a natural leader for our people, company, partners, and customers around the country.”

“I am excited for the opportunity to build upon and execute against the important vision Dr. Silliman curated at this incredible organization, arm and arm with our board and growing executive team,” said Williamson. “I have large shoes to fill and plan to double down on our commitment to the customer experience and making all Sensiva products and service lines accessible to both the largest and smallest organizations in the country. I’m driven daily by the dedication to quality and worth ethic of our incredible team. Sensiva truly is a once in a lifetime company and the opportunity to lead it fills me with great pride and gratitude.”

A statement from the Board of Directors:

“On behalf of Sensiva Health, we want to sincerely thank Dr. Silliman for his contributions to our company, and his dedication to our employees and mission as CEO. In the face of extreme adversity and global challenge, Jim importantly remained focused on our customers while improving the lives of the people within our organization and nurturing the culture he created. The foundation Dr. Silliman cultivated is unparalleled in our industry and we are forever grateful for his service as CEO. Looking ahead, we’re eager to uncover the value and expertise Dr. Silliman will bring to the board and could not be more optimistic about the direction of Sensiva Health under Williamson’s leadership.” – Sensiva Health Board of Directors

Sensiva Health is a cutting-edge infection prevention and technology driven healthcare solutions company. From our enterprise infection prevention and control services to industry leading molecular diagnostics and software solutions, Sensiva provides the science, technology, and infrastructure to power critical healthcare initiatives for our most vulnerable population and their providers. Their headquarters and molecular laboratory (Cormeum Lab Services) are located in New Orleans, LA, while Sensiva Health Manufacturing is located in Maple Grove, MN. Sensiva / Cormeum serve all 50 states nationally.

TOLL-FREE (888) 813-0742
EMAIL hello@sensivahealth.com
LinkedIn – Sensiva Health

View original content to download multimedia:https://www.prnewswire.com/news-releases/sensiva-health-names-ben-williamson-as-chief-executive-officer-302253757.html

SOURCE Sensiva Health

Continue Reading

Technology

Former VinFast Deputy CEO Stuart Taylor joins Envorso as Chief Product Officer

Published

on

By

Taylor brings leadership experience from both traditional and startup automakers to help improve manufacturers’ software product development

DETROIT, Sept. 23, 2024 /PRNewswire/ — Envorso, a software consulting firm that supports the modernization of the automotive and manufacturing industries, is adding Stuart Taylor as the company’s chief product officer (CPO) to provide even more depth to its leadership team. Taylor brings 30 years of automotive experience to the Envorso team, with past leadership roles in both traditional automakers and a start-up electric vehicle manufacturer.

Taylor previously served as Deputy CEO and member of the Executive Board for VinFast, where he was responsible for the start-up’s transformation from a domestic EV manufacturer into a global contender. Prior to joining VinFast, he helped shape the technical direction of iconic brands like Aston Martin Lagonda, drove innovation and technology growth at Land Rover and served in a number of roles at Ford Motor Company where he helped to transform the customer experience by leveraging the technology intersection of hardware, software and data. 

“Stuart brings valuable experience to our customers, built over decades of leading automotive software teams for both traditional and startup manufacturers,” said Scott Tobin, CEO of Envorso. “His unique perspective and proven experience on both sides of the industry will be an asset to our team and our customers. Taylor will provide automotive and manufacturing leaders with a new way of thinking and working, helping them transform their businesses and products to meet the demands of a software-driven future.”

As CPO, Taylor will lead software product consulting for Envorso’s customers – with a focus on toolchain and process development for automakers and manufacturers seeking more effective and efficient development of software products.

“Automotive software development practices vary significantly between traditional automakers and startups in the industry – and each stands to learn valuable lessons from the other,” said Taylor. “I look forward to helping leaders adopt the best of both worlds and better understand what is needed from a process, tool and talent perspective to develop innovative and reliable technologies for the software-defined vehicle.”

For more information on Taylor and Envorso’s leadership team, visit: https://envorso.com/our-leadership/.

About Envorso

Envorso is a software consulting firm that supports the modernization of the automotive and manufacturing industries. Founded in 2016, Envorso consultants bring proven experience leading teams and product development from the automotive, manufacturing and software industries together to help bridge the gap between Silicon Valley software development and traditional automotive and industrial companies. To learn more, visit www.envorso.com.

View original content:https://www.prnewswire.com/news-releases/former-vinfast-deputy-ceo-stuart-taylor-joins-envorso-as-chief-product-officer-302254794.html

SOURCE Envorso

Continue Reading

Technology

Unlock Health Launches Health Risk Assessment (HRA) Product Suite to Enhance the Consumer Journey to Care and Drive Growth Across Key Service Lines

Published

on

By

Unlock’s 19 condition-specific HRAs are designed to enhance operational efficiency and boost patient acquisition and retention strategies across key service lines.

NASHVILLE, Tenn., Sept. 23, 2024 /PRNewswire/ — Unlock Health, a tech-enabled growth platform for healthcare systems, hospitals, provider groups, and treatment center facilities, today announced the launch of its advanced suite of Health Risk Assessments (HRA). This first-of-its-kind HRA suite contains 19 condition-specific assessments designed to empower healthcare marketing leaders with first-party data to create more customized marketing campaigns, enhance operational efficiencies and support organizational growth.

Due to complex privacy and data regulations, provider organizations have significant gaps in patient population data, making it difficult to reach the communities that would benefit most from early intervention. The condition-specific assessments, ranging from joint pain and heart health to diabetes and sleep apnea, are engineered to provide rich and contextual patient insights to better stratify health risk, support follow-up and engage at-risk patients in care. For patients and their families, Unlock HRAs use the latest screening and health advisory data to help them assess individual risks and provide education and information to make more informed decisions about their care.

Feedback from Franciscan Health, an early adopter of Unlock HRAs, demonstrates significant impact and creates a new model for how other organizations can leverage HRAs to drive service line growth. In 2023, Franciscan Health received over 3,400 completed assessments, consistently exceeding benchmark completion rates.

“Using condition-specific assessments like Heart, Breast, Lung, Knee & Hip, Weight, Sleep, Colon, and Vascular, we’ve been able to reach a broader audience and tailor our outreach more precisely,” said Kirsten Wachowski of Franciscan Health. “The insights from Unlock HRAs improve screening and follow-up, especially in specialties like Heart and Lung care, helping us engage our communities more effectively with early intervention strategies, guiding our patients at the right time in their health journey.”  

The HITRUST, HIPAA-compliant HRAs from Unlock Health feature a modern and intuitive user interface that provides patients with a seamless, multichannel experience and equips healthcare organizations with analytics reporting tools to improve marketing efforts and better engage patients around their care. The Unlock HRAs also offer robust integration with healthcare CRM and marketing automation systems for ongoing communication and nurturing campaigns.

“These aren’t ordinary Health Risk Assessment products. By combining the best-in-class features from legacy Medicom and HealthAware products with new functionality like custom questions and configurable CTAs, Unlock HRAs set a new standard in the industry,” said Dan Lavelle, Chief Product Officer at Unlock Health. “Our HRAs enhance security and compliance, which is what clients expect from a HITRUST-certified product, and maximize campaign performance. Clients who have integrated Unlock HRAs with performance marketing have seen significant improvements in campaign performance, reducing their service line cost per acquisition an average of 48%.”

For more information about Unlock Heath HRAs, please visit: https://go.unlockhealthnow.com/unlock-hras/   

About Unlock Health
Unlock Health is a new kind of full-service agency that drives sustainable growth for healthcare organizations by seamlessly integrating marketing, technology, and revenue strategy. From breakthrough campaigns to leading conversion models, we accelerate the go-to-market process and align marketing spend with business priorities. Headquartered in Nashville, Tennessee, Unlock Health stands as the largest marketing and advertising agency exclusively focused on U.S. healthcare providers and health services, boasting a team of 328 professionals. Visit us at https://www.unlockhealthnow.com and join us in reshaping the future of healthcare.

View original content to download multimedia:https://www.prnewswire.com/news-releases/unlock-health-launches-health-risk-assessment-hra-product-suite-to-enhance-the-consumer-journey-to-care-and-drive-growth-across-key-service-lines-302254546.html

SOURCE Unlock Health

Continue Reading

Trending